Medvi vs Found Weight Loss (2026)

Medvi and Found are both cash-pay GLP-1 telehealth programs, but they operate at opposite ends of the clinical depth spectrum. Medvi is built for lowest-friction, lowest-cost prescription access. Found is built around clinical matching — identifying which medication (or combination) is most appropriate for each patient's metabolic profile. The decision between them depends on whether price or clinical optimization is the priority.

---

Quick Comparison

	Medvi	Found
Monthly cost	~$99–149/month	~$99–199/month
GLP-1 access	Compounded semaglutide, tirzepatide	Compounded + some insurance navigation
Non-GLP-1 medications	No	Yes — bupropion/naltrexone, topiramate, metformin, spironolactone
Insurance navigation	No	Yes — insurance team
Medication matching	Default to GLP-1	Algorithm-based matching to best medication
Coaching	Minimal	App-based health coaching
Provider access	Async primarily	Async + scheduled visits
PCOS support	No	Spironolactone available
Clinical complexity handled	Low-complexity, straightforward cases	Moderate-complex; multi-comorbidity

---

Medvi: Lean and Low-Cost

Medvi's value proposition is clear: the most affordable path to compounded GLP-1. The intake is questionnaire-based, prescribers review asynchronously, and medications ship directly from the compounding pharmacy. No program fee beyond the prescription cost.

Who Medvi works well for:

• Straightforward GLP-1 candidates (BMI ≥30, no complex comorbidities)
• Patients who have already done the research and know they want compounded semaglutide or tirzepatide
• Price-sensitive patients prioritizing low monthly cost
• Self-directed patients who don't need coaching or clinical handholding

Medvi limitations:

• Does not prescribe medications beyond GLP-1
• No insurance navigation
• Minimal clinical support for non-response or side effect management
• Less established than Found (smaller track record)

---

Found: Clinical Matching for Better-Fit Outcomes

Found's clinical model recognizes that GLP-1 is not the optimal first-line medication for all patients. Their algorithm and medical team evaluate eating patterns, metabolic history, and comorbidities to match patients to:

• GLP-1 agonists (semaglutide, tirzepatide) — hunger-driven obesity, metabolic reset needed
• Bupropion/naltrexone — reward-pathway and craving-driven eating
• Topiramate — specific eating pattern profiles
• Metformin — insulin resistance foundation
• Spironolactone — PCOS-related androgen/weight management (women)
• Combinations — frequently used at Found; multiple mechanisms simultaneously

Who Found works well for:

• Patients who have tried GLP-1 and failed (different mechanism may be needed)
• Women with PCOS (spironolactone access is a meaningful differentiator)
• Patients with emotional eating, binge eating, or craving-driven patterns
• Those who want insurance navigation help alongside medication
• Patients who want ongoing coaching alongside prescribing

Found limitations:

• Higher program cost than Medvi at the upper end
• Insurance navigation is present but not specialist-level (Calibrate or Sequence are stronger)
• Clinical matching requires more intake information and possibly more time to first prescription

---

The Medication Matching Question

For most patients, GLP-1 is the right first-line choice — and for those patients, Medvi's lower cost with the same medication is the better option. But for patients in specific profiles, Found's matching capability matters:

Patient Profile	Better Platform	Why
Standard GLP-1 candidate, wants lowest cost	Medvi	Same medication, lower cost
Failed GLP-1 before, needs different mechanism	Found	Bupropion/naltrexone or combination
PCOS, needs spironolactone	Found	Not available at Medvi
Primarily reward/craving eating pattern	Found	Bupropion/naltrexone more appropriate
New to weight loss treatment, wants guidance	Found	Coaching and clinical matching add value
Cost-first, knows GLP-1 is right	Medvi	Lower monthly cost straightforward

---

Pricing

Plan	Medvi	Found
Monthly program	~$99–149	~$99–199
Annual estimate	~$1,188–1,788	~$1,188–2,388
Annual cost difference	—	+$0–600 vs Medvi

The cost differential is modest ($0–50/month depending on Found tier chosen). For patients who need Found's clinical depth, this difference is easily justified. For pure GLP-1-seeking patients, Medvi's savings are real.

---

Related Resources

• Found Weight Loss Review — full program review
• Medvi Weight Loss Review — full program review
• Medvi vs Ro GLP-1 — Medvi vs established platform
• Found vs Sequence Weight Loss — Found vs insurance navigation specialist
• GLP-1 Non-Responders FAQ — what to do when GLP-1 isn't working